Theriva Biologics, Inc.TOVXNYSE
Loading
Free Cash Flow Growth TrendStable
Percentile Rank50
5Y CAGR-9.8%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-9.8%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2024 | 11.77% |
| 2023 | 0.00% |
| 2022 | -48.78% |
| 2021 | -5.97% |
| 2020 | 12.23% |
| 2019 | 19.74% |
| 2018 | 15.33% |
| 2017 | 28.29% |
| 2016 | 27.72% |
| 2015 | -144.25% |